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A B S T R A C T
The primary objective of the study was to evaluate the correlation between prostaglandin F2-alpha and tumour necro-
sis factor-alpha concentration and that of pain experienced by patients undergoing thermal balloon ablation. Further-
more we evaluated the correlation between the endometrial and myometrial thicknesses and the degree of pain experi-
enced by patients undergoing the procedure, and in addition the correlation between PGF2-alpha, TNF-alpha and endo-
metrial and myometrial thicknesses. Single-arm cohort study (Canadian Task force classification II-2). In University
Medical Centre Ljubljana, outpatient setting, 40 perimenopausal women with dysfunctional uterine bleeding (DUB), un-
derwent endometrial thermal balloon ablation. The thickness of the endometrium and myometrium was measured prior
to surgery using a transvaginal ultrasound that provided cross-sectional images. The degree of pain was rated using the
visual analogue scale (VAS) and numeric rating scale (NRS) immediately and 60 minutes after the procedure. The con-
centration of PGF2-alpha and TNF-alpha in venous blood was measured prior to, at the end of and 60 minutes after the
procedure. The results showed a positive correlation between the concentration of PGF2-alpha released during endo-
metrial ablation and the endometrial and myometrial thickness (p>0.01), including the reported degree of pain (p>
0.01). The concentration of TNF-alpha indicates a positive correlation with the level of pain (p>0.05), but is not depend-
ent on the thicknesses of the endometrium and myometrium. Endometrial thickness correlates to the degree of pain and
the prostaglandin F2-alpha concentration. In clinical practice, performing the Gynecare ThermaChoice procedure im-
mediately after menstruation or preoperative preparation of the endometrium using oral contraceptives enables this pro-
cedure to be performed in outpatient settings and can be considered a valuable treatment option for DUB.
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Introduction
Dysfunctional uterine bleeding is excessive genital
tract bleeding (more than 80 mL) in the absence of any
pathology1,2.
Approximately 15% of clinic visits in the gynaecologi-
cal practice are due to abnormal uterine bleeding2,3. They
occur in 20% of women between the ages of 30 and 501.
In 1978, Neuwirth introduced resectoscopes, which
was an alternative method to hysterectomy. It was a new
and minimally invasive treatment for menorrhagia – us-
ing endometrial ablation or hysteroscopic transcervical
resection of the endometrium (TCRE)4. However, the
procedure was not as well established as was expected,
because it was performed under general anaesthesia,
meaning that preoperative endometrial preparation with
hormonal drugs was required, with 7% of cases resulting
in major surgical complications. The risk of hypervo-
lemia is described and success of the procedure depends
on the experience of the surgeon4,5.
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Therefore, non-hysteroscopic endometrial ablation
which was non-surgical became much more accepted6,7
endometrial ablation with circulating hot saline solution,
and with different thermal balloons or bipolar electro-
des8,9.
Despite the established preoperative treatment by ad-
ministering non-steroid anti-inflammatory drugs (NSAIDs),
known as antiprostaglandins with an injection (or pill),
moderate to severe pain occurs in 25% of patients10.
This requires intravenous application of analgesics or
even anaesthesia as well as postoperative administration
of strong analgesics11. This represents a certain limita-
tion for an exclusively ambulatory procedure.
The primary objective of the study was to evaluate the
correlation between prostaglandin F2-alpha together
with tumour necrosis factor-alpha and pain in patients
undergoing thermal balloon ablation.
Additional objectives involved determining the con-
centration of PGF2 alpha and TNF alpha released during
the procedure and analyzing correlations between the
following parameters: PGF2 alpha and TNF alpha con-
centrations against the degree of pain, endometrial and
myometrial thicknesses and the degree of pain, PGF2 al-
pha and TNF alpha concentrations against endometrial
and myometrial thicknesses.
Positive correlations would imply the need for preop-
erative endometrial preparation using oral contracep-
tives or by performing a procedure immediately after
menstrual bleeding. This would allow endometrial abla-
tion, to be performed in outpatient settings as an alter-
native to hysterectomy.
Methods
The study was performed in the Clinical Department
for Reproduction at the Department of Obstetrics and
Gynaecology in Ljubljana where TC (Gynecare Therma-
choice Il, USA) was introduced back in 2001. It was ap-
proved by the Ethics Committee and carried out in accor-
dance with GCP and the Declaration of Helsinki.
All women referred to our outpatient clinic over a pe-
riod of one year (October 2008 – October 2009) with dys-
functional uterine bleeding were offered the Thermo-
Choice (TC) thermal balloon ablation. Pathological endo-
metrial changes were excluded by performing diagnostic
curettage or diagnostic hysteroscopy along with endo-
metrial biopsy over a 6-month period prior to this study
procedure. Women that had previously undergone any
type of endometrial ablation were excluded from the
study.
Forty women agreed to the TC procedure and gave
their informed consent prior their participation in the
study.
The procedure itself has been in clinical use at the
mentioned department since 2001 and has been per-
formed in accordance to the manufacturer’s instructions.
Before the procedure, bimanual and speculum exami-
nation of each patient was performed, as along with a
transvaginal ultrasound examination of the uterus and
adnexa. The thickness of the endometrium and myome-
trium was measured in cross-sectional images.
To prevent pain, non-steroid anti-inflammatory drugs
(NSAIDs) are commonly used prior to the TC procedure.
To discover the role of prostaglandins in the cause of pain
experienced by patients in the study, we administered
100 mg of tramadolum i.m instead of the NSAIDs. This
does not affect the synthesis of prostaglandins. Further-
more, 5 mg of diazepamum was also administered orally
one hour prior to the procedure. The procedure per-
formed was a paracervical block with 1% of Xylocain ad-
ministered.
The degree of pain was measured and evaluated using
the visual analogue scale (VAS) and the numeric rating
scale (NRS) immediately after the procedure and 60 min-
utes later. PGF2-alpha and TNF-alpha concentrations in
venous blood was measured three times: at the start of
the procedure, at the end (lasting 8 minutes) and 60 min-
utes after the procedure. The procedural times were uni-
form across all 40 procedures.
Determination of PGF2-alpha and TNF-alpha concen-
trations were performed from frozen samples at the Clin-
ical Institute of Clinical Chemistry and Biochemistry.
The immuno-enzymatic method performed using a la-
belled ligand and done once for each parameter.
The correlation between endometrial and myometrial
thickness, PGF2-alpha and TNF-alpha concentrations
and the degree of pain using VAS and NRS was statisti-
cally evaluated.
For the purpose of statistical analysis, a linear regres-
sion method was used. Correlation statistics (Pearson,
Spearman) were performed to determine whether a sta-
tistically significant correlation existed between the dif-
ferent factors, e.g. the endometrial thickness and degree
of pain. The paired samples t-test was used for normally
distributed parameters. For parameters that were not
normally distributed, nonparametric statistic methods
were applied (Fridman test and Wilcoxon test).
Each patient had been informed about the aim and
course of the study. Once patients decided to participate
in the study, they signed an informed consent form con-
firming their voluntary participation.
The sample size calculation was based on a 95% confi-
dence level estimation of the frequency of patients with
moderate to severe pain (25%) after TC. With 60 TC pa-
tients introduced a year at the Department of Obstetrics
and Gynaecology in Ljubljana, 40 patients included in
the study meant that an estimate of this prevalence with
a confidence interval of 7.0% (0.18–0.32) was possible.
Results
The baseline characteristics of the cohort studied are
shown in Table 1. TC was successfully completed in all 40
women (100% of the participants).
During and 60 minutes after the procedure, the study
provided different concentrations of PGF2-alpha with a
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statistically significant difference between the following
three measurements (Fridman test): c2 =25.56; df=2;
p<0.001. While modest changes the PGF2-alpha concen-
trations before and at the end of the procedure were dis-
covered, the PGF2-alpha concentration from the third
measurement was significantly lower compared to the
two previous measurements, i.e. before and at the end of
the procedure: (p<0.001 and p<0.01) (Paired t-test).
The TNF-alpha concentration did not change signifi-
cantly for the three measurements: c2=2.52; df=2; p=
0.284 (Fridman test).
The difference in the examined parameters from the
subgroups of patients based on cycle phase is showed in
Table 2. In the TC patient subgroup possessing prolife-
rative (phase 1) PGF2-alpha, there is a significant differ-
ence between the 1st and 3rd measurements (p<0.05).
There is no significant TNF-alpha difference between
any of three measurements in this patient group.
In the group possessing the secretory (phase 2) PGF2-
-alpha concentration, at the third measurement was sig-
nificantly lower compared to both measurements – be-
fore the procedure and at the end of the procedure:
(p<0.001 and p<0.01). The TNF-alpha concentration at
the third measurement was significantly lower when
compared to both other measurements, i.e. before and at
the end of the procedure: (p<0.05) (Paired t-test).
Upon evaluating the PGF2-alpha and TNF-alpha con-
centration, and the degree of pain (according to VAS), the
results showed a statistically significant positive correla-
tion (p<0.01) between the PgF2-alpha concentration be-
fore the procedure and degree of pain at the end of the
procedure with the whole procedure lasts for 8 minutes.
The study also discovered a statistically significant
positive correlation (p<0.01) between the PGF2-alpha
concentration measured 60 minutes after the procedure
(3rd measurement) and degree of pain evaluated at the
same time.
A statistically significant positive correlation (p<0.05)
was also found between the TNF-alpha measured at 60
minutes after the procedure and degree of pain at the
end of procedure. This indicates that a higher TNF-alpha
concentration measured one hour after the procedure
corresponds to a higher degree of pain at the end of the
procedure.
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TABLE 1







Mean age (years) 43.3±4.7 44.9±3.5 44.4±4.0
Uterine sounding length (<10 cm) 8.27±10.6 8.66±7.1 8.53±7.6
Endometrial thickness (mm) 6.43±3.8 9.42±5.1* 8.38±4.9
Myometrial thickness (mm) 18.29±3.8 20.9±3.5* 20.00±3.84
Data are presented as X±SD or N (%); *p<0.05 vs proliferative phase
TABLE 2


































–1.73 –3.89 –2.91 –0.64 –1.84 –1.61




–1.55 –2.30 –1.34 –0.71 –0.03 0.66




–0.93 –3.22 –2.53 –0.32 –2.12 –2.53
p value NS <0.001 <0.01 NS <0.05 <0.05
Differences between three measurements of PGF2-alpha in TNF-alpha concentrations (NS=not statistically significant)
In evaluating the correlation between the endome-
trial/myometrial thickness and the degree of pain, posi-
tive correlations were also calculated (Figures 1 and 2).
Figure 1 shows that a thicker endometrium is associ-
ated with higher levels of pain during and after the pro-
cedure (p<0.01), whereas Figure 2 shows the same for a
thicker myometrium.
A positive correlation (p<0.01) between the PgF2-al-
pha concentration before the procedure against endome-
trial and myometrial thicknesses was also calculated.
The PGF2–alpha concentration before the procedure
correlates to the thicknesses of the endometrium and
myometrium and the degree of pain.
A correlation between the quantity of TNF-alpha and
endometrium and myometrium thicknesses was not ob-
served.
Discussion
The purpose of our study was to determine the corre-
lation between the prostaglandin F2-alpha (PGF2-alpha)
concentration and tumour necrosis factor-alpha (TNF-al-
pha), against the degree of pain together with endo-
metrial and myometrial thicknesses in patients undergo-
ing TC thermal balloon ablation.
For many years prostaglandins have been recognized
as key molecules in endometrial physiology and in endo-
metrial glands and menstruation. More recently, a role
for COX enzymes and prostaglandins has been ascer-
tained in reproductive tract pathology, including dysme-
norrhea, endometriosis and menorrhagia12.
The cause of pain is not completely known but it is
mainly attributed to prostaglandins, particularly PGF2-
-alpha13 and is commonly used in preoperative treatment
in which upon the administering of antiprostaglandin
agents – NSAIDs, pain is significantly reduced.
On the other hand, Laberge et al. 2003 in a prospec-
tive double-arm study, comparing intraoperative and post-
operative pain in relation with two modes of non-hyste-
roscopic ablation, showed that frequency and the degree
of pain depend on the duration of the procedure (Nova-
Sure, Hologic, USA 2 min., TC 8 min.) and not on the
amount of prostaglandins released. The shorter proce-
dure results in a lower degree of pain14. The question
which remains is why the degree and intensity of pain
greatly differs in the same group of patients undergoing
the same (TC) procedure.
In our study, we found that the endometrial and
myometrial thicknesses show a positive correlation when
compared to the degree of both intraoperative and post-
operative pain (Figures 1 and 2).
A statistically significant difference among the three
PGF2-alpha measurements was found. The third PGF2-
-alpha concentration was in statistical terms significant-
ly lower (Table 2). This finding indicates that during
endometrial ablation with TC, PGF2-alpha is released
and shows a positive correlation to the degree of pain re-
corded on the VAS and NRS scales.
Higher concentrations of PGF2-alpha before the pro-
cedure are released from the thicker endometrium and
myometrium and correspond to a higher degree of pain
during and after the procedure (2nd measurement). This
is confirmed by our results, because none of the patients
with an endometrium thicker <5 mm experienced pain
>5 according to VAS (Table 3) (Fisher exact test p<
0.001).
Furthermore, the degree of pain was significantly
lower in patients with an endometrial thickness <5 mm.
Significantly lower concentrations of PGF2-alpha one
hour after the procedure corresponded to a lower degree
of pain at that same time.
Tumor necrosis factor alpha (TNF-alpha), one of the
tumour markers for endometriosis, is released from the
endometrium during the secretory phase and causes
hemorrhagic cell necrosis15,16.
TNF-alpha was released during and after the proce-
dure but not to the extent observed with PGF2-alpha,
and did not show any statistically significant differences
in concentrations (Table 2). These concentrations re-
mained stable throughout three measurements.
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Fig. 1. Correlation between endometrial thickness (mm) and the
degree of pain (VAS score) during the procedure.
Fig. 2. Correlation between myometrial thickness (mm) and the
degree of pain (VAS score) during the procedure.
Higher TNF-alpha concentrations one hour after the
procedure showed a correlation with a higher degree of
pain during and after the procedure. However, the TNF-
-alpha concentration showed no correlation with endo-
metrial and myometrial thicknesses.
A possible objection to the study could be that the
PGF2-alpha samples were obtained from venous blood.
This is particularly so if given that most of the prosta-
glandins metabolized during the first passage through
the lungs. However, the purpose of the study was to find
only changes in PGF2-alpha concentrations and not the
absolute values released, which was less invasive and ag-
gravating for patients. Further studies will be necessary
to confirm these findings.
Ultrasound (US) measurements of the cross-sectional
images were performed by two authors from the US,
both highly skilled and experienced. In addition, 40 con-
secutive patients who fulfilled inclusion criteria were re-
cruited in the study during over a one-year period.
In the treatment of menorrhagia TC represents an ef-
ficient alternative to the significantly more invasive hys-
terectomy17,18 and can be performed in 87% of patients in
outpatient settings19.
Finding from previous studies showed that adminis-
tration of an oral contraceptive pill (OC) in the prolife-
rative phase of the cycle maintains a very thin, flat endo-
metrium20.
Therefore, in performing the thermal endometrial ab-
lation procedure immediately after the menstruation, or
if preparation of endometrium is done preoperatively
with oral contraceptives (if not contraindicated), it would
allow the procedure to be performed in outpatient set-
tings without the need for anaesthesia.
This assumption should be further tested and vali-
dated in a future well thought out study.
Conclusions
The intraoperative and postoperative degree of pain
in women undergoing TC endometrial ablation is in di-
rect correlation with the released PGF2-alpha, and which
subsequently shows a positive correlation with endo-
metrial and myometrial thicknesses.
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TABLE 3
CORRELATION OF ENDOMETRIAL THICKNESS AND PAIN SCORE
Endometrial thickness <5 mm Endometrial thickness >5 mm
N°of patients 15 25
N°of patients VAS I score>5 0** 25
N°of patients VAS II score>5 0** 25
Average pain score VAS I 3.13±1.18 6.60±1.52##
Average pain score VAS II 2.00±1.64 3.56±1.96#
* Data are presented as N or X±SD; ** Fisher exact test p<0.001; # Student’s t-test p<0.05, ## Student’s t-test p<0.01.
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UTJECAJ PROSTAGLANDINA F2-ALFA FAKTORA TUMORSKE NEKROZE-ALFA (TNF-a) NA BOL
U PACIJENATA PODVRGNUTIH TERMALNOJ ENDOMETRIJSKOJ BALON ABLACIJI
S A @ E T A K
Osnovni cilj istra`ivanja bio je procijeniti korelaciju izme|u prostaglandina F2-alfa i nekroze tumora koncentracije
faktor-alfa te boli koju osje}aju bolesnici podvrgnuti toplinskoj balon ablaciji. Nadalje, procijenili smo korelaciju izme|u
endometrijske i miometrijske debljine i stupnja boli koju do`ivljavaju pacijenti koji prolaze postupak, a osim toga i
korelaciju izme|u PGF2-alfa, TNF-alfa i endometrijske i miometrijske debljine. Provedeno je jednostruko kohortno
istra`ivanje (Canadian Task force classification II-2) u sveu~ili{nom medicinskom centru u Ljubljani, u dnevnim bolni-
cama. 40 `ena pred menopauzu s disfunkcionalnim krvarenjem iz maternice (DUB), pro{le su endometrijalnu toplin-
sku balon ablaciju. Endometrijska i miometrijska debljina mjerena je prije operacije koriste}i transvaginalni ultrazvuk
koji pru`a presjek slike. Stupanj boli ocijenio se pomo}u vizualne analogne skale (VAS) i broj~ane skale ocjena (NRS)
neposredno nakon i 60 minuta nakon zahvata. Koncentracija PGF2-alfa i TNF-alfa u venskoj krvi mjerene su prije, na
kraju, i 60 minuta nakon postupka. Rezultati su pokazali pozitivnu korelaciju izme|u koncentracije PGF2-alfa tijekom
ablacije endometrija i endometrijske i miometrijske debljine (p<0,01), uklju~uju}i i izmjeren stupanj boli (p<0,01).
Koncentracija TNF-alfa pokazuje pozitivnu korelaciju s razinom boli (p<0,05), ali nije ovisna o endometrijskoj i mijo-
metrijskoj debljini. Endometrija debljina korelira sa stupnjem boli i koncentracijom prostaglandina F2-alfa. U klini~koj
praksi, izvo|enje postupka Gynecare ThermaChoice odmah nakon menstruacije ili predoperativne pripreme endome-
trija kori{tenjem oralnih kontraceptiva omogu}uje da se ovaj postupak obavlja u ambulantnim uvjetima i mo`e se
smatrati vrijednim tretmanom za DUB.
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